Get the app!
Back to Companies

CNS Pharmaceuticals, Inc.

CNSPNasdaqCIK: 0001729427

Over the 12 most recent insider filings, CNS Pharmaceuticals, Inc. (CNSP) has seen activity from 9 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $34.0K bought versus $0 sold, a net purchase of $34.0K. Climaco John M (Chief Executive Officer, Director) is the most active by dollar volume, and the single largest transaction was $292.8K by Climaco John M. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$567.9K
Purchases
$34.0K
Sales
$0
Unique Insiders
9

Recent Insider Trades

12 loaded
May 20CNSP
CNS Pharmaceuticals, Inc.
Charles Faith L.DirectorBuy$34.0K
Mar 4CNSP
CNS Pharmaceuticals, Inc.
Faulkner EricChief Technology OfficerOther$0
Mar 4CNSP
CNS Pharmaceuticals, Inc.
Faulkner EricChief Technology OfficerAward$0
Jan 2CNSP
CNS Pharmaceuticals, Inc.
Levin RamiCEO and President, DirectorAward$0
Jan 2CNSP
CNS Pharmaceuticals, Inc.
Levin RamiCEO and President, DirectorOther$0
Nov 19CNSP
CNS Pharmaceuticals, Inc.
Mahery AmyDirectorAward$18.9K
Nov 19CNSP
CNS Pharmaceuticals, Inc.
Keyes Jeffry R.DirectorAward$18.9K
Nov 19CNSP
CNS Pharmaceuticals, Inc.
Climaco John MChief Executive Officer, DirectorAward$292.8K
Nov 19CNSP
CNS Pharmaceuticals, Inc.
Gumulka JerzyDirectorAward$18.9K
Nov 19CNSP
CNS Pharmaceuticals, Inc.
Charles Faith L.DirectorAward$18.9K
Nov 19CNSP
CNS Pharmaceuticals, Inc.
Cockroft Bettina M.DirectorAward$18.9K
Nov 19CNSP
CNS Pharmaceuticals, Inc.
Downs ChristopherChief Financial OfficerAward$146.4K

12 filings